Clinical Trial Title: Radioembolization Oncology Trial Utilizing Transarterial Eye90 (ROUTE 90) for the Treatment of Hepatocellular Carcinoma (HCC)
- Status: IRB Approved (IRB Support: Marc Mccall)
- PI Name: Ammar Sarwar
- Main Coordinator: Usman Shami
- Manager Support: Ema Pinjic
- ClinicalTrials.gov Identifier: NCT05953337
https://clinicaltrials.gov/ct2/show/NCT05953337
Clinical Trial Title: A Prospective, Randomized, Open-Label Study to Examine The Effects of a Pressure-Enabled Drug Delivery Device on Radiotracer Distribution Compared to a Standard Microcatheter in the Context of Radioembolization
- Status: IRB Approved (IRB Support: Marc Mccall)
- PI Name: Ammar Sarwar
- Main Coordinator: Usman Shami
- Manager Support: Ema Pinjic
- ClinicalTrials.gov Identifier: NCT05128032
https://clinicaltrials.gov/ct2/show/NCT05128032
Clinical Trial Title: A prospective, multicenter, open-label single-arm study evaluating the safety and efficacy of selective internal radiation therapy (SIRT) using SIR-Spheres® Y-90 resin microspheres on duration of response (DoR) and objective response rate (ORR) in unresectable hepatocellular carcinoma (HCC) patients (DOORwaY90 Study)
- Status: IRB Approved (IRB Support: Marc Mccall)
- PI Name: Ammar Sarwar
- Main Coordinator: Usman Shami
- Manager Support: Ema Pinjic
- ClinicalTrials.gov Identifier: NCT04736121
https://clinicaltrials.gov/ct2/show/NCT04736121
Clinical Trial Title: A Single-Arm Phase 2 Study of Y-90 SIRT in combination with durvalumab (MEDI 4736) and gemcitabine/cisplatin in locally advanced, unresectable, or metastatic intrahepatic cholangiocarcinoma
- Status: IRB Approved (IRB Support: CCTO Team)
- PI Name: Andrea Bullock; Co-I A. Sarwar
- Main Coordinator: CCTO Team
- Manager Support: CCTO Team
- ClinicalTrials.gov Identifier: NCT05655949